WebJul 28, 2024 · LabCorp, a global life sciences company, is pursuing a spin-off of its wholly owned Clinical Development business, which will result in two independent, publicly traded companies:. Labcorp: A global laboratory business comprising the Company’s routine and esoteric labs, central labs and early development research labs, all of which are leaders … WebJul 28, 2024 · July 28, 2024, 1:33 AM · 1 min read (Adds details, background) July 28 (Reuters) - Diagnostics company Labcorp plans to spin off its unit focused on clinical drug trials, the Wall Street...
UPDATE 1-Labcorp to spin off clinical-development business
WebJul 28, 2024 · (Reuters) - Laboratory Corp of America Holdings said on Thursday it would spin off its wholly owned business focused on clinical drug trials, sending its shares up … WebJul 28, 2024 · The planned spin-off the Clinical Development business will increase its agility with large pharmaceutical and biotechnology clients to advance the development of life-saving therapies and better serve its customers. Through an arrangement, the business will retain access to Labcorp’s health and clinical data set that will allow it to offer ... how to rent to own house
LabCorp to Spin-Off Clinical Development Business
WebJul 28, 2024 · July 28 (Reuters) - Laboratory Corp of America Holdings (LH.N) said on Thursday it would spin off its wholly owned business focused on clinical drug trials, … WebFeb 14, 2024 · 14 Feb 2024 Labcorp says clinical trials spin off Fortrea will focus on agility, innovation and “delivering life-changing solutions faster.” The firm shared details of the Fortrea plan this week just ahead of its end of year call, which is scheduled for February 16. WebFeb 9, 2024 · Fortrea (pronounced for-TREE-ah) will be the name of Labcorp’s (NYSE: LH) planned clinical development spin-off. The brand announcement comes a month after Labcorp named industry veteran Tom... how to rent to visiting nurses